• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

VPNW.com

virtual publishing network

  • About
  • Sponsored Post
  • Make a Contribution
  • Contact

Sanofi launches dedicated vaccines mRNA Center of Excellence

June 29, 2021 By admin Leave a Comment

Approximately €400million investment annually to accelerate end-to-end R&D of next-generation vaccines, fully financed through resource reallocation

Focus on innovating mRNA vaccines beyond pandemic to routine use in diseases with high unmet need

Expected minimum of six clinical candidates by 2025

PARIS – Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate the development and delivery of next-generation vaccines by bringing together approximately 400 dedicated employees integrating end-to-end mRNA vaccine capabilities with dedicated R&D, digital, and chemistry, manufacturing and controls (CMC) teams across sites at Cambridge, MA (US) and Marcy l’Etoile, Lyon (France).

“During the COVID-19 pandemic, mRNA technologies demonstrated potential to deliver new vaccines faster than ever before. However, key areas of innovation such as thermostability and tolerability improvements will be critical to unlock the applications of mRNA in routine vaccination against a broader set of infectious diseases and across all ages. The Sanofi mRNA vaccines Center of Excellence aims to lead the field in this next chapter of vaccine innovation,” said Jean-Francois Toussaint, Global Head of Research and Development, Sanofi Pasteur.

The Center of Excellence will enable acceleration of the vaccines mRNA portfolio developed through the Translate Bio collaboration established in 2018 and expanded in 2020.

“This massive new investment clearly puts us in the race to develop next-generation vaccines where mRNA technologies can have greatest impact.” said Thomas Triomphe, Executive Vice President, Global Head of Sanofi Pasteur. “While mRNA won’t be the solution for every infectious disease, its translation into routine prevention could have immense impact for many unmet public health needs. It now becomes a critical new technology in our comprehensive vaccines toolbox, one which could help reinvent health protection in the future.”

Sanofi is committed to rapidly establishing an industry-competitive mRNA platform and is working with our partners and all relevant stakeholders, internally and externally, to achieve this objective.

About Sanofi
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Source: Sanofi

Related

Filed Under: News Tagged With: mRNA, vaccine

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Opinion

Ukraine: anyone looking to take up arms against Russian forces to enlist
Andrei Kozyrev: If we “blink” on Putin’s nuclear threat, we will increase the risk of WWIII
Justin Trudeau: Western countries should have a united front against China
Russia is not in position to challenge West militarily in a long & costly war
Interview with Stephen Kotkin: Putin’s miscalculation
Donating to assist Ukraine relief efforts
Ovation TV Statement on the Russian Invasion of Ukraine

Press Media Release

Clarivate Names World’s Leading Journals with the 2022 Journal Citation Reports
Adorama Business Solutions Launches Federal Government Purchasing Portal
Bezos Earth Fund Announces First Commitments to Marine Protection at UN Ocean Conference
Russia is now just hours away from its first foreign default
How are key trends shaping marketing and public relations?
EPPA : New Study Shows That Making Reusable Containers for Takeaway Obligatory Will Undermine the EU’s Environmental Goals
SYSTECH is to Exhibit Fully Integrated Container and Fleet Tracking Solutions in Mexico

Secondary Sidebar

GameTech Market

Ubisoft Announces Riders Republic™
Mobile game publisher Jam City raises $350M and buys Ludia for $165M
Logitech G Introduces G915 TKL, a More Compact Tenkeyless Gaming Keyboard
Game On Announces Marie-Hélène Weiss as Head of Production
UBISOFT ANNOUNCES DEPARTURES AND REAFFIRMS ITS COMMITMENT TO IMPLEMENTING SIGNIFICANT CHANGE IN ITS WORKPLACE CULTURE
Tom Clancy’s Rainbow Six® Extraction Launches on September 16
Gunfire Reborn, a FPS+Roguelite game, is on Steam “Top Sellers”
Pick a Side and Scramble Your Starfighters in Star Wars™: Starfighter Missions!
GDC 2022 Returns to San Francisco as an In-Person Event March 21 – 25, 2022
Roblox Raises $150M in Series G Financing, Led by Andreessen Horowitz

Footer

Recent Posts

  • As a technical writer, it’s pretty common to do the thing you’re documenting
  • Most Platforms Fail
  • Adaptability Paradox
  • Fear holds back innovation efforts
  • Technology Digest
  • Forward-thinking companies are moving towards industry-specific marketing strategy
  • What did the latest consumer survey find about streaming services?
  • Cloudflare suffered an outage that affected global Internet traffic
  • AI-based transcription tools have made one particularly tiresome aspect of journalism far easier
  • THE NEW AGE OF TECH TALENT: EXPERIS RELEASES NEW REPORT SHOWING ‘SOFT SKILLS ARE THE NEW POWER SKILLS’

Media Partners

  • Pixel Effect
  • Digital Market
  • Briefly
  • OPINT
  • Exclusive
  • S3H
  • Domain Aftermarkets

Media Partners

  • Technology Conferences
  • Event Sharing Network
  • Defense Conferences
  • Cybersecurity Events
  • Event Calendar
  • Calendarial
  • Domain Market Research
  • Domain Name for Business

Copyright © 2018 VPNW.com

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT